Dr. Shoko Takahashi of Shonan Beauty Clinic Shinjuku Main Hospital Presents Periorbital Collagen Injection Research at AMWC Asia-TDAC 2026 in Taipei

Dr. Shoko Takahashi of Shonan Beauty Clinic Shinjuku Main Hospital, which receives management support from SBC Medical Group Holdings Incorporated, headquartered in California, United States and led by CEO Yoshiyuki Aikawa, presented research findings at the international medical conference “AMWC Asia-TDAC 2026,” held in Taipei, Taiwan, over three days from Friday, May 1, 2026. AMWC Asia-TDAC is an international academic conference jointly held by Aesthetic Medicine World Congress (AMWC), one of the world’s largest international conferences in aesthetic medicine and dermatology, and the Taiwan Dermatology Aesthetic Conference (TDAC), organized by the Taiwanese dermatology community. Specialists and researchers in dermatology and aesthetic medicine from across Asia and around the world gather to share the latest treatment technologies and clinical insights. At AMWC Asia-TDAC 2026, Dr. Takahashi gave a presentation titled “Strategic use of injectable collagen for periorbital rejuvenation.” The periorbital area is a region where age-related skin thinning and collagen loss are especially visible, and delicate approaches using collagen formulations have attracted growing international attention in recent years. Dr. Takahashi shared practical insights on strategically applying the latest collagen injection techniques to periorbital rejuvenation treatment. Her presentation drew strong interest from physicians and researchers from various countries for its potential to improve treatment safety and efficiency while contributing to a more reassuring medical experience. In recent years, technological innovation has advanced rapidly in the field of aesthetic medicine, increasing the importance of knowledge sharing and academic collaboration beyond clinical practice. To respond to diversifying needs, the introduction of cutting-edge technologies must be accompanied by a broad perspective and flexible thinking. SBC Medical Group will continue to promote advanced initiatives through academic activities and international exchange with research institutions, while working to improve the safety, transparency, and sustainable value of aesthetic medicine. AMWC Asia-TDAC 2026 was held at the Taipei International Convention Center in Taipei, Taiwan, from Friday, May 1 to Sunday, May 3, 2026. The official website is https://www.amwc-asia.com/en/home.html. The presentation title was “Strategic use of injectable collagen for periorbital rejuvenation.” Dr. Shoko Takahashi graduated from Juntendo University Faculty of Medicine and trained in the Department of Anesthesiology at Nippon Medical School Hospital. After working in aesthetic dermatology, she joined Shonan Beauty Clinic in 2021. She specializes in both cosmetic surgery and aesthetic dermatology, handling many cases mainly in facial contouring and rejuvenation treatments. She is known for proposals tailored to each customer’s bone structure, age-related changes, and lifestyle, and aims to provide aesthetic medical care that helps patients feel more positive from within through careful counseling. She is also actively involved in improving the technical capabilities and safety of aesthetic medicine through research presentations at academic conferences in Japan and overseas. SBC Medical Group Holdings Incorporated is a Medical Services Organization that provides management support to medical institutions in Japan and overseas across a wide range of fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The group operates diverse clinic brands and is also expanding globally through medical tourism and business development in the United States and Asia. It listed on the NASDAQ market in September 2024 and was selected for inclusion in the Russell 3000 U.S. stock index in June 2025. The group will continue expanding its network and providing reliable medical services in pursuit of its purpose: contributing to improving people’s happiness around the world through medical innovation.